{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:29:43Z","timestamp":1758961783703},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T00:00:00Z","timestamp":1447804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10637-015-0301-z","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T05:22:54Z","timestamp":1447824174000},"page":"1-14","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin\u2019s lymphoma: an in vitro and in vivo study"],"prefix":"10.1007","volume":"34","author":[{"given":"Jin Sun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Won","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Shil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Ho","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieun","family":"Uhm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Woong","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Bae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hye","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Yiul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,18]]},"reference":[{"issue":"6","key":"301_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1470-2045(04)01490-1","volume":"5","author":"BT Hennessy","year":"2004","unstructured":"Hennessy BT, Hanrahan EO, Daly PA (2004) Non-Hodgkin lymphoma: an update. Lancet Oncol 5(6):341\u2013353","journal-title":"Lancet Oncol"},{"issue":"23","key":"301_CR2","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1158\/1078-0432.CCR-04-1028","volume":"10","author":"CL Law","year":"2004","unstructured":"Law CL et al (2004) Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates. Clin Cancer Res Off J Am Assoc Cancer Res 10(23):7842\u20137851","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"301_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"71","author":"WS Velasquez","year":"1988","unstructured":"Velasquez WS et al (1988) Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71(1):117\u2013122","journal-title":"Blood"},{"issue":"6","key":"301_CR4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","volume":"12","author":"WS Velasquez","year":"1994","unstructured":"Velasquez WS et al (1994) ESHAP\u2013an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol Off J Am Soc Clin Oncol 12(6):1169\u20131176","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"23","key":"301_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333(23):1540\u20131545","journal-title":"N Engl J Med"},{"issue":"1","key":"301_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2007-01-041871","volume":"110","author":"JO Armitage","year":"2007","unstructured":"Armitage JO (2007) How I treat patients with diffuse large B-cell lymphoma. Blood 110(1):29\u201336","journal-title":"Blood"},{"issue":"Suppl 2","key":"301_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","volume":"6","author":"S Waxman","year":"2001","unstructured":"Waxman S, Anderson KC (2001) History of the development of arsenic derivatives in cancer therapy. Oncologist 6(Suppl 2):3\u201310","journal-title":"Oncologist"},{"issue":"18","key":"301_CR8","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","volume":"19","author":"SL Soignet","year":"2001","unstructured":"Soignet SL et al (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol Off J Am Soc Clin Oncol 19(18):3852\u20133860","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"301_CR9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1517\/14656566.9.10.1773","volume":"9","author":"MR Litzow","year":"2008","unstructured":"Litzow MR (2008) Arsenic trioxide. Expert Opin Pharmacother 9(10):1773\u20131785","journal-title":"Expert Opin Pharmacother"},{"issue":"14","key":"301_CR10","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1158\/1078-0432.CCR-07-4572","volume":"14","author":"P Phatak","year":"2008","unstructured":"Phatak P et al (2008) KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells. Clin Cancer Res Off J Am Assoc Cancer Res 14(14):4593\u20134602","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"1","key":"301_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/toxsci\/kfu029","volume":"139","author":"CS Muenyi","year":"2014","unstructured":"Muenyi CS, Trivedi AP, Helm CW, States JC (2014) Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells. Toxicol Sci Off J Soc Toxicol 139(1):74\u201382","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"301_CR12","doi-asserted-by":"publisher","first-page":"747415","DOI":"10.1155\/2014\/747415","volume":"2014","author":"SR Woo","year":"2014","unstructured":"Woo SR et al (2014) KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis. BioMed Res Int 2014:747415","journal-title":"BioMed Res Int"},{"issue":"7","key":"301_CR13","first-page":"3469","volume":"34","author":"MH Yang","year":"2014","unstructured":"Yang MH et al (2014) KML001 inhibits cell proliferation and invasion in pancreatic cancer cells through suppression of NF-kappaB and VEGF-C. Anticancer Res 34(7):3469\u20133474","journal-title":"Anticancer Res"},{"issue":"15","key":"301_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0960-9822(01)00328-1","volume":"11","author":"F d\u2019Adda di Fagagna","year":"2001","unstructured":"d\u2019Adda di Fagagna F et al (2001) Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr Biol 11(15):1192\u20131196","journal-title":"Curr Biol"},{"issue":"3","key":"301_CR15","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","volume":"37","author":"RM Cawthon","year":"2009","unstructured":"Cawthon RM (2009) Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37(3):e21","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"301_CR16","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273(10):5858\u20135868","journal-title":"J Biol Chem"},{"issue":"2","key":"301_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ceb.2007.02.009","volume":"19","author":"J Bartek","year":"2007","unstructured":"Bartek J, Lukas J (2007) DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 19(2):238\u2013245","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"301_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/ncb1337","volume":"8","author":"A Jazayeri","year":"2006","unstructured":"Jazayeri A et al (2006) ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8(1):37\u201345","journal-title":"Nat Cell Biol"},{"issue":"2","key":"301_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/mol.111.076752","volume":"82","author":"B Zhang","year":"2012","unstructured":"Zhang B et al (2012) Telomere and microtubule targeting in treatment-sensitive and treatment-resistant human prostate cancer cells. Mol Pharmacol 82(2):310\u2013321","journal-title":"Mol Pharmacol"},{"issue":"5293","key":"301_CR20","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr CJ (1996) Cancer cell cycles. Science 274(5293):1672\u20131677","journal-title":"Science"},{"issue":"5381","key":"301_CR21","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"NA Thornberry","year":"1998","unstructured":"Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281(5381):1312\u20131316","journal-title":"Science"},{"issue":"21","key":"301_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","volume":"19","author":"T Bowman","year":"2000","unstructured":"Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19(21):2474\u20132488","journal-title":"Oncogene"},{"issue":"5164","key":"301_CR23","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264(5164):1415\u20131421","journal-title":"Science"},{"issue":"7","key":"301_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489\u2013501","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"301_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11912-012-0227-y","volume":"14","author":"L Willems","year":"2012","unstructured":"Willems L et al (2012) PI3K and mTOR signaling pathways in cancer: new data on targeted therapies. Curr Oncol Rep 14(2):129\u2013138","journal-title":"Curr Oncol Rep"},{"issue":"16","key":"301_CR26","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","volume":"23","author":"T Wada","year":"2004","unstructured":"Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23(16):2838\u20132849","journal-title":"Oncogene"},{"key":"301_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin Jr","year":"1996","unstructured":"Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649\u2013683","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"301_CR28","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1128\/MCB.19.4.2690","volume":"19","author":"M Hinz","year":"1999","unstructured":"Hinz M et al (1999) NF-kappaB function in growth control: regulation of cyclin D1 expression and G0\/G1-to-S-phase transition. Mol Cell Biol 19(4):2690\u20132698","journal-title":"Mol Cell Biol"},{"issue":"4","key":"301_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.febslet.2004.11.036","volume":"579","author":"EH Blackburn","year":"2005","unstructured":"Blackburn EH (2005) Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett 579(4):859\u2013862","journal-title":"FEBS Lett"},{"issue":"2 Pt 1","key":"301_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0092-8674(85)90170-9","volume":"43","author":"CW Greider","year":"1985","unstructured":"Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43(2 Pt 1):405\u2013413","journal-title":"Cell"},{"issue":"5","key":"301_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/carcin\/bgh296","volume":"26","author":"JW Shay","year":"2005","unstructured":"Shay JW, Wright WE (2005) Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26(5):867\u2013874","journal-title":"Carcinogenesis"},{"issue":"10","key":"301_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1172\/JCI14064","volume":"108","author":"WC Chou","year":"2001","unstructured":"Chou WC, Hawkins AL, Barrett JF, Griffin CA, Dang CV (2001) Arsenic inhibition of telomerase transcription leads to genetic instability. J Clin Invest 108(10):1541\u20131547","journal-title":"J Clin Invest"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-015-0301-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0301-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-015-0301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:50:09Z","timestamp":1678510209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-015-0301-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1007\/s10637-015-0301-z","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,18]]},"assertion":[{"value":"26 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Hanyang University Hospital and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.All procedures performed in studies involving animals were in accordance with the ethical standards of Seoul National University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}